CompletedNot Applicable

Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images

China1,500 participantsStarted 2023-09-01

Plain-language summary

Rising thyroid carcinoma rates, with papillary thyroid carcinoma (PTC) as the main type (85-90% of cases), often show early cervical lymph node spread. This increases the risk of PTC patients for recurrence and death. A new study's multimodal model fuses preoperative US and cytology images to better predict lymph node metastasis, aiming to improve treatment plans, reduce unnecessary surgeries, and enhance patient outcomes.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Underwent thyroidectomy and bilateral lymph node dissection with pathological confirmation of PTC * Completed US examination within one week before surgery * Underwent preoperative us-guided FNAC * Completed cytological images at 400× magnification under a microscope Exclusion Criteria: * Patients who underwent only unilateral thyroidectomy * Patients with cervical lymph nodes shown on preoperative ultrasound

What they're measuring

Presence or absence of lymph node metastasis

Timeframe: October 2024

Trial details

NCT IDNCT06399159

SponsorNanchong Central Hospital

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2024-03-01

View on ClinicalTrials.gov More Papillary Thyroid Carcinoma trials